Upload Avatar (500 x 500)
Xu Gezhi
xugezhi@sohu.com
Chinese, English
Shanghai
Fudan University
Brain Science Research Institute
  • 1985 - Bachelor's Degree: Shanghai Medical University
  • 1995 - Master's Degree in Philosophy: Chinese University of Hong Kong
  • Published over 60 papers in high-level journals
  • Translated and edited 2 monographs
  • Received 3 provincial and ministerial awards
  • Current - Professor of Clinical Medicine at Fudan University
  • Current - Vice President and Chief Physician at Fudan University Eye and ENT Hospital
  • Current - Member of the American Vitreoretinal Society
  • 5 times recipient of the National Education Commission, Ministry of Health, and Shanghai Science and Technology Progress Award
Mechanisms of glial cell activation and neuronal apoptosis in retinal degenerative diseases and diabetic retinopathy
  • Regional macular light sensitivity changes in myopic Chinese adults: a micro perimetry 1 study, Qin YW, Zhu MJ, Qu XM, Xu GZ*, Yu YF, Witt RE, Wang WJ, 2010
  • ERK1/2 signaling pathways involved in VEGF release in diabetic rat retina, Ye XF, Xu GZ*, Chang Q, Fan JW, Sun ZC, Qin YW, Jiang AC, 2010
  • Naloxone has neuroprotective effects against light-induced photoreceptor degeneration through inhibiting retinal microglia activation, Ni YQ, Xu GZ*, Hu WZ, Shi L, Qin YW, Da CD, 2008
  • Neuroprotective effect of transcorneal electrical stimulation on light-induced photoreceptor degeneration, Ni YQ, Gan DK, Xu HD, Xu GZ*, Da CD, 2009
  • Dendritic abnormalities in retinal ganglion cells of three-month diabetic rats, Qin YW, Xu GZ*, Wang WJ, 2006
Glial Cells Neuronal Apoptosis Retinal Degeneration Diabetic Retinopathy Mechanisms Activation Neuroprotection Research Ophthalmology Disease

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.